Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × pasireotide × Clear all

NCT01639352 2017-07-12

Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

Phase 2 Completed

20 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular